Patents Represented by Attorney Congping Xie
  • Patent number: 7494651
    Abstract: The present invention provides very high affinity antibodies, or antigen-binding fragments thereof, that neutralize mature human TGF-?1, TGF-?2, and TGF-?3. The antibodies of the invention are useful for treating cell proliferative disorders in a mammal.
    Type: Grant
    Filed: December 20, 2006
    Date of Patent: February 24, 2009
    Assignee: Eli Lilly and Company
    Inventors: Bryan Edward Jones, James D. Pancook, Scott William Rowlinson